Echinocandins for the Treatment of Invasive Aspergillosis: from Laboratory to Bedside

Authors:

Abstract
Echinocandins (caspofungin, micafungin, anidulafungin), targeting β-1,3-glucan synthesis of the cell wall, represent one of the three currently available antifungal drug classes for the treatment of invasive fungal infections. Despite their limited antifungal activity against Aspergillus spp., echinocandins are considered an alternative option for the treatment of invasive aspergillosis (IA).
Funding Information
  • Swiss National Science Foundation (PZ00P3 161140)
  • Fondation Santos-Suarez pour la Recherche Médicale

This publication has 93 references indexed in Scilit: